Accure

Quick links to important sections

Accure

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Accure

Quick Facts

Property Description
Active ingredient Isotretinoin (13-cis-retinoic acid)
Form Oral Soft Gelatin Capsules
Pharmacological class Systemic Retinoid, Anti-Acne Agent
Common use Management of severe, resistant skin issues
Origin Synthetic Derivative of Vitamin A

What Type of Medicine is Accure (Isotretinoin)?

Accure is a powerful prescription-only medication whose active ingredient is Isotretinoin, chemically identified as 13-cis-retinoic acid. This substance is formally classified as a systemic retinoid, which places it in a pharmacological group fundamentally related to and derived from Vitamin A. This synthetic derivative is clinically recognized for its efficacy in difficult-to-treat dermatological cases. The medication is specifically differentiated from standard topical treatments by its systemic approach, acting throughout the body rather than just on the skin's surface.


What Form Does Accure Take and What Is It Made Of?

Accure is administered as an oral soft gelatin capsule, defining its direct and simple oral route of administration. The preparation is a single-ingredient product, containing only Isotretinoin as the therapeutic agent. Because Isotretinoin is a highly lipophilic compound, meaning it readily dissolves in fats, it is typically formulated by suspending or dissolving the active substance in an inert oily vehicle within the capsule shell. This formulation is essential for ensuring efficient systemic absorption and bioavailability, which is a key pharmacological feature of the product.


What is the General Purpose of Taking a Systemic Retinoid?

The primary general purpose of Accure is to correct the underlying cellular pathology responsible for severe, persistent skin problems. It functions primarily by causing a dramatic reduction in the size and output of the sebaceous glands, significantly decreasing the skin's sebum (oil) production. This profound effect on oil production is the core mechanism by which this class of retinoids achieves therapeutic success in conditions like nodulocystic acne. In addition to reducing oil, the medication works to regulate the natural shedding process of skin cells, helping to normalize keratinization and prevent pore blockages. By controlling the source of excess oil and maintaining open pores, Accure offers a means to clear and improve overall skin quality for its target audience.

Regulatory References

  1. Isotretinoin - StatPearls - NCBI Bookshelf

What side effects are possible with Accure?

Possible Side Effects and Safety Information

The safety profile of Accure (Isotretinoin) is comprehensively documented in official regulatory sources, which outline its potential adverse reactions and mandatory safety constraints. Many adverse reactions are classified based on frequency, which helps define the expected physiological effects.

Frequency Classification Examples of Documented Adverse Reactions
Very Common (>10%) Cheilitis (inflamed lips), Dry skin, Dry eyes, Epistaxis (nosebleeds), Arthralgia (joint pain), Increased Transaminases, Elevated Triglycerides
Common (1%–10%) Headache, Anemia, Conjunctivitis, Thrombocytopenia

Adverse effects are documented across several System-Organ Classes, including the Skin and Subcutaneous Tissue Disorders, Musculoskeletal System, Hepatobiliary System, and Psychiatric System. The common effects involving the skin and mucous membranes are generally dose-dependent and contribute to the frequent side effect profile.

Serious Adverse Reactions and Safety Constraints

Official labeling highlights the primary serious safety concern: Teratogenicity. Isotretinoin is strictly contraindicated in pregnancy due to the high risk of severe birth defects, necessitating participation in a mandatory Pregnancy Prevention Programme for all females of childbearing potential. Rare but clinically significant reactions documented in regulatory sources include Inflammatory Bowel Disease, Hepatitis, Benign Intracranial Hypertension, and severe psychiatric reactions such as suicidal ideation.

Population and Concomitant Use Restrictions

Specific restrictions apply to minimize risk: the drug is contraindicated for individuals with severe hepatic impairment. Routine monitoring of lipid profiles and liver function tests is required throughout treatment. Furthermore, regulatory documents explicitly restrict concomitant use of Vitamin A supplements and tetracycline-class antibiotics due to the potential for compounded toxicity risks.

Overdose and Emergency Response

Acute overdose of Accure (Isotretinoin) typically results in manifestations that align with descriptions of acute hypervitaminosis A. Documented presentations, which affect the neurological, gastrointestinal, and mucocutaneous systems, include acute systemic symptoms such as headache, dizziness, ataxia (loss of coordination), vomiting, abdominal pain, and facial flushing. Additionally, cheilosis (severe chapped lips) is a documented clinical sign.

Regulatory labeling specifies that these acute systemic symptoms are generally rapidly reversible and resolve quickly without the need for specific intervention or apparent residual effects. The documented management for these transient acute signs is symptomatic and supportive.

Nevertheless, the regulatory profile establishes a critical population-specific constraint: Patients who can become pregnant who present with an overdose must immediately seek medical attention and undergo a mandated pregnancy evaluation. This immediate, non-negotiable action is required because of the severe, life-threatening risk of teratogenicity, which involves the potential for severe congenital malformations and spontaneous abortion following fetal exposure to the drug. Consequently, when an overdose is suspected, official government guidance mandates the patient to contact a poison control center or emergency room at once, prioritizing the assessment of fetal risk over the management of acute transient symptoms.

Therapeutic Uses of Accure

What Accure Treats: Main Uses and Benefits

The medication is a systemic agent relevant for severe, persistent skin problems. It is relevant for conditions characterized by periods of heightened symptoms, such as severe nodular acne and related recalcitrant inflammatory disorders.

This treatment is commonly applied in scenarios where patients experience deep, persistent nodules and painful cystic lesions, and is commonly used when supportive symptom management is appropriate. This includes conditions such as acne conglobata and severe papulopustular acne. It is relevant for managing symptoms that interfere with daily comfort, such as excessive oil production (hyperseborrhea).

Accure helps the patient during difficult episodes by easing distress and may assist with supportive management related to symptoms that create noticeable physiological strain, like significant scarring. This approach supports general well-being during symptomatic phases and helps improve day-to-day comfort, which is relevant across therapeutic domains involving heightened responses related to the significant psychosocial burden.

Quick Fact: Relevant for Severe Nodular Acne

Eligibility and Restrictions for Use

Accure (Isotretinoin) eligibility is strictly defined by government regulatory documents, centering on reproductive risk and pre-existing medical conditions.

Contraindicated Populations (Must Not Use)

Category Regulatory Status
Pregnancy Absolutely Contraindicated due to extremely high risk of severe birth defects (teratogenicity).
Breastfeeding Contraindicated (may pass into breast milk).
Liver/Metabolic Contraindicated in hepatic insufficiency, Hypervitaminosis A, and excessively elevated blood lipid values.
Allergy Contraindicated in known hypersensitivity to the active ingredient or its components.

Eligibility and Age Restrictions

The medicine is generally indicated for non-pregnant adolescents (12 years and older) and adults with severe recalcitrant nodular acne. Use is not recommended in children younger than 12 or for prepubertal acne, as safety and efficacy are not established in these groups. Older adults may require caution due to a higher likelihood of serious unwanted effects.

Conditions Requiring Restricted Use

For patients with severe renal insufficiency (severe kidney disease), treatment should be initiated at a lower starting dose. Additionally, patients with Diabetes or a family history of bone disorders should be treated with caution.

What should I know about interactions with other medicines?

Official Regulatory Interaction Profile for Accure (Isotretinoin)

This profile summarizes the officially documented interaction constraints and prohibitions for Accure as stated in government regulatory documents.

Interaction Classification Interacting Substance/Condition Regulatory Basis
Contraindicated Combinations Tetracycline Antibiotics Risk of Intracranial Hypertension (Pseudotumor Cerebri).
Vitamin A Supplements Risk of additive toxicity (Hypervitaminosis A).
Progestin-Only Oral Contraceptives Compromised contraceptive efficacy.
Use with Caution Phenytoin, Systemic Corticosteroids Potential for additive effects on bone abnormalities.
Clearance Restriction Hepatic Insufficiency Contraindicated due to risk of accumulation.

Official Interaction Statements and Constraints

The medicine’s systemic exposure is officially enhanced when administered with a high-fat meal; this administration context is required for proper absorption. Regulatory documents strictly prohibit the co-administration of Tetracycline antibiotics and Vitamin A supplements to avoid severe, additive toxic effects.

For reproductive safety, Progestin-Only Oral Contraceptives are prohibited for use as they are not deemed acceptable for birth control while taking this medicine. St. John’s Wort requires caution as it may interfere with the efficacy of hormonal contraceptives. Furthermore, due to the potential for additive strain, alcohol use requires caution, as both substances may increase the risk of lipid metabolism disorders. The product is also contraindicated in patients with a soya or peanut allergy due to the capsule excipient.

Mechanism of Action

How Accure Works


Nuclear Receptor Agonism and Gene Regulation

Accure's core mechanism begins when its active form, all-trans-retinoic acid, functions as an agonist by binding to and activating specific Retinoic Acid Receptors ( RARs) inside the cell nucleus. This interaction modulates gene expression by altering the transcriptional rate of target genes, particularly those controlling cell differentiation and programmed cell death. This process initiates the comprehensive modulation of cellular activity within the pilosebaceous unit.


Sebocyte Apoptosis and Gland Involution

The changes in gene expression directly induce apoptosis (programmed cell death) in the oil-producing sebocytes, causing the sebaceous glands to undergo significant involution (shrinkage). This anatomical and functional change leads to a strong suppression of oil (sebum) production, consequently altering the follicular environment by minimizing the substrate for bacterial proliferation and potential keratinous accumulation.


Keratinization and Anti-Inflammatory Modulation

The drug's mechanism also works to normalize the differentiation and shedding (keratinization) of skin cells lining the hair follicle, inhibiting the abnormal adhesion of dead cells that contributes to follicular occlusion. Furthermore, it exerts a direct anti-inflammatory action by downregulating specific signaling molecules, thereby contributing to the downregulation of the local inflammatory cascade within the skin tissue.

Dosage and Administration Information

How Accure is Used (Official Administration Guidelines)

Accure (Isotretinoin) is a prescription-only systemic retinoid whose usage is defined by clinical guidelines. Administration is exclusively via the oral route, taken as a soft gelatin capsule. The regimen is structured as a weight-based course that is discontinued once a specific total dose is reached, rather than being used indefinitely.


Administration Principles and Regimen

The daily dose is calculated according to the patient’s body weight, typically ranging from 0.5 to 1 mg/ kg/ day. This dose is usually administered in two divided doses daily. A core administration requirement is that the capsules must be taken with a meal to ensure appropriate systemic absorption; some formulations specifically require a high-fat meal. Capsules are intended to be swallowed whole and should not be crushed or chewed.


Course Duration and Total Dose

Treatment follows a fixed course duration, generally spanning 15 to 24 weeks. The ultimate therapeutic endpoint is reaching a total cumulative dose, typically in the range of 120 to 150 mg/ kg. If a dose is missed, patients should skip that dose and continue with the next scheduled dose, not taking two doses at once. A second treatment course, if deemed necessary, should not be initiated until at least two months have elapsed after the completion of the first course.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Accure

Evidence Overview for Reducing Racial Disparities in Early-Stage Cancer Treatment Completion

Research for this area involved large, practical quality improvement studies, including observational groups and some randomized components. These studies applied non-drug interventions focused on standardized communication and patient navigation to explore differences in care between groups. Researchers measured outcomes related to treatment plan adherence, such as the percentage of patients completing their full planned course of treatment (which includes surgery, radiation, and/or chemotherapy) within set timeframes. They also studied patient satisfaction and longer-term survival measurements at five years.

Reports indicated that the navigation and communication protocols were associated with changes measured during the study period, particularly in the percentage of patients completing their full course of treatment. It is important to understand that unblinded assessment was involved in measuring outcomes, which may introduce some uncertainty. Long-term outcomes beyond the five-year survival measurements are not fully established.

Evidence Overview for Appendectomy as an Adjunctive Treatment in Ulcerative Colitis Remission

Trial data evaluated the use of an appendectomy procedure alongside standard medical care for Ulcerative Colitis (UC) to measure outcomes associated with changes in the disease course for patients already in clinical remission. The trials measured the primary outcome, which was the number of UC relapses recorded over a one-year follow-up period. Other outcomes examined included patient-reported outcomes describing perceived discomfort and measures of disease activity.

Reports described patterns related to the cumulative relapse rate recorded at the one-year mark between the group receiving standard therapy plus appendectomy and the control group. Because the research involved a surgical procedure versus a non-surgical approach, participants and treating physicians were not blinded to the treatment assignment. This factor, combined with the limited follow-up durations, means long-term effects are not fully established.

What Remains Uncertain or Unstudied About the Research

Studies so far have primarily focused on short-term changes. The evidence is limited regarding the full scope of outcomes, especially concerning long-term follow-up. For the UC study, the early cessation of the main trial means the sample size was smaller than planned, and variability in findings was observed in some subgroup analyses. Few data are available for special populations like pregnant individuals or children. Research does not determine whether an individual will respond similarly, as findings describe group patterns, not personal outcomes.

Frequently Asked Questions (FAQ)

Common questions about Accure (FAQ)

Q: How quickly can a person expect Accure to start working?

Official information indicates that while you may notice some changes early on, clinical improvement is related to the overall reduction in oil secretion. Improvements may continue for up to eight weeks after the prescribed course of treatment is completed.


Q: Is Accure known to interact with common over-the-counter pain relievers?

Regulatory documents do not explicitly list common over-the-counter pain relievers (OTC) as prohibited interactions. However, because the body processes this medicine using the liver, careful consideration and monitoring may be advised for any drugs that may also affect how the liver functions.


Q: Do studies suggest a link between Accure and long-term organ function?

Research has generally focused on shorter-term outcomes and effects. Official guidance indicates that further studies are necessary to gain a deeper insight into potential long-term effects of the medicine after a person stops treatment.


Q: What should a person do if they feel Accure isn't working for them?

Official guidelines advise that clinical improvement may continue for up to eight weeks after the treatment course is finished. If a full course has been completed and there is discussion of starting a second course, official guidelines specify that a waiting period of at least two months is necessary after the first course has ended.


Q: What is the difference between Accure and the generic version of the medicine?

The active ingredient in both the brand name (Accure) and the generic versions is isotretinoin. Some formulations, depending on how they are manufactured, are not interchangeable on a milligram-to-milligram basis. These differences may affect how the formulation is prescribed or administered.


Q: Does Accure affect a person's ability to drive or operate machinery?

The official product labeling indicates that the medicine can rarely affect a person's vision. This can include a decrease in the ability to see clearly at night. Due to the possibility of decreased night vision, caution is advised when driving or operating heavy machinery.


Q: What should be done if someone accidentally takes too much Accure?

If a person suspects or confirms that they have taken too much of the medicine, official guidance directs that a healthcare professional or a poison control center should be contacted right away.


Q: Is Accure ever prescribed for conditions other than the main approved use?

Accure is approved by the FDA only for the treatment of severe recalcitrant nodular acne that has not been helped by other conventional therapies. The official prescribing information is restricted to severe recalcitrant nodular acne.


Q: What is the typical timeframe before the full effect of Accure is usually seen?

Since improvement continues over time, the full effect of the medicine is often not seen until after the treatment course is finished. Clinical improvement has been observed to continue for up to eight weeks after the full course of treatment is completed.


Q: Can Accure cause sensitivity to sunlight?

Patients are cautioned that the medicine may increase sensitivity to ultraviolet (UV) light. Official guidance suggests avoiding excessive sunlight and artificial UV lights, and using sunscreen.


Q: Why is Accure sometimes confused with a different medicine having a similar name?

Official safety warnings note that the name Accutane (a former brand name for the active ingredient) may be confused with other drug names like Accolate or Accupril due to similar sounds. Additionally, the active ingredient isotretinoin is sometimes confused with the similar medicine tretinoin.


Q: Can Accure be safely used by people with a history of heart problems?

While heart problems are not listed as a strict reason not to use the medicine, it is known to elevate blood lipid values, such as triglycerides and cholesterol. This requires routine monitoring throughout treatment, and patients with a family history of lipid metabolism disorders may require careful consideration.


Q: Is Accure considered a high-alert medication by health organizations?

Yes, regulatory and safety organizations like the Institute for Safe Medication Practices (ISMP) include this medicine in their list of High-Alert Medications. This classification indicates that the medicine has been associated with a heightened risk of causing significant patient harm if it is used incorrectly.


Q: What does the term 'contraindication' mean in relation to using Accure?

A contraindication is a condition where official sources prohibit the use of a medicine due to a high risk of harm. For this medicine, the primary and most significant contraindication is pregnancy, due to the extreme risk of severe birth defects.


Q: Do official documents mention any effects of Accure on fertility?

Official warnings focus most strongly on the risk of severe birth defects (teratogenicity). However, recent regulatory reviews have advised strengthening product information to include warnings about potential sexual dysfunction.


Q: What is the standard regulatory warning about stopping Accure suddenly?

Regulatory guidance addresses the risk of psychiatric symptoms. If treatment is stopped due to symptoms of depression, a further psychiatric evaluation may be considered. This is because the symptoms may not be fully relieved immediately upon discontinuation of the medicine.


Q: Why do people sometimes report a lack of effect from Accure?

The official product label notes that acne may temporarily worsen when a person first starts using the medicine. Additionally, the full therapeutic effect relies on the completion of the entire prescribed dose and duration of treatment, with improvements continuing even after the course is finished.


Q: How is the success of treatment with Accure generally measured in clinical trials?

In clinical trials, the success of the treatment is measured primarily based on the reduction in the nodule count (the number of severe acne lesions). This reduction is the main criterion used for determining both the treatment duration and the overall efficacy of the medicine in severe recalcitrant nodular acne.


Q: What should be done if a specific side effect mentioned in the leaflet occurs?

Official safety documents state that the medicine should be discontinued and a physician or healthcare provider contacted immediately if serious side effects are experienced. These serious side effects include symptoms of depression, severe headaches, vision changes, or signs of liver damage.


Q: Why do some official sources emphasize the need for caution with certain activities while on Accure?

Caution is emphasized for specific activities to prevent complications. Official regulatory sources specify that certain activities, such as blood donation and specific cosmetic procedures (e.g., waxing or laser treatments), are restricted during and for a period after treatment.


Q: Is Accure the same kind of medicine as other treatments for this condition?

Accure is classified as a systemic retinoid, which is a type of medicine fundamentally related to Vitamin A. This classification and its severe acne indication distinguish it from standard topical treatments and oral antibiotic therapies commonly used for the condition.


Q: Are there any specific foods or drinks to avoid while using Accure?

The product label specifies that Vitamin A supplements must be avoided due to the risk of additive toxicity. Alcohol requires caution because both substances may increase the risk of lipid metabolism disorders. It is also required that the medicine be taken with a meal to ensure proper absorption.


Q: Are there any known issues with combining Accure with herbal supplements?

Official regulatory documents specifically state that St. John’s Wort requires caution. This is because it may interfere with the efficacy of hormonal contraceptives, which are a required part of the mandatory Pregnancy Prevention Programme.


Q: Are there different forms or strengths of Accure available?

The medicine is available as oral capsules in various strengths, typically 10 mg, 20 mg, 30 mg, and 40 mg. It is important to know that these different formulations or strengths may not be directly interchangeable due to different absorption characteristics.


Q: Is it normal to feel a mild side effect like dry mouth when first starting Accure?

Yes, common side effects of the medicine frequently involve dryness in the mucous membranes, including dry lips, dry eyes, and dry nostrils. While dry mouth is not always explicitly listed, the widespread occurrence of this type of dryness across mucous membranes is considered normal when starting treatment.


Q: What is the likelihood of experiencing a rare but serious side effect from Accure?

Serious psychiatric events, such as suicidal ideation, are classified as rare. Large reviews have indicated that the absolute risk of suicide or suicidal ideation during use is generally very low.


Q: Do clinical guidelines suggest starting Accure at a low amount?

While the standard range is determined by body weight, low-dose regimens are sometimes used as an alternative treatment for moderate acne. Additionally, official documents specify that a lower starting dose is necessary for patients who have severe renal insufficiency (severe kidney disease).

How should Accure be stored and disposed of?

How to Store and Dispose of Accure (Isotretinoin)

Accure must be stored and handled according to specific conditions mandated by regulatory labeling to maintain stability and ensure safety.


Storage Requirements

Accure requires storage at controlled room temperature, specifically between 59 F and 86 F (15 C and 30 C). The medication must be protected from light and kept away from excessive heat. It is required to keep the product in the original container and ensure the container remains tightly closed. A mandatory safety requirement is to keep the product out of the reach of children.


Disposal Instructions

Unused or expired Accure must be disposed of in accordance with local regulatory requirements. Disposal should utilize official medicine take-back programs or a pharmacist's guidance. The product must not be flushed down a toilet or poured into a drain unless explicitly instructed by a regulatory body.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Accure found in:

A-Z Index: